PHARMACY

Alembic gets FDA OK for generic Optivar

BY Sandra Levy

Alembic Pharmaceuticals has received the Food and Drug Administration’s approval for azelastine hydrochloride ophthalmic solution, 0.05%.

The product is the generic of Mylan’s Optivar.

Azelastine hydrochloride ophthalmic solution 0.05% is indicated for the treatment of itching of
the eye associated with allergic conjunctivitis.

The product had a market value of roughly $8.5 million for the 12 months ended December 2018, according to IQVIA.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer